CEO Sell resigns; agilon posts $104M Q2 net loss, suspends 2025 guidance

agilon health, inc.

Steven Sell resigned as CEO/President and Board director effective July 29; Board reduced to seven directors.
Executive Chairman Ron Williams appointed; Office of the Chairman formed to oversee interim operations.
Q2 total revenue $1.39B (-6% YoY); net loss $104M vs $31M loss in Q2 2024.
Medical margin negative $53M vs positive $106M; adjusted EBITDA loss $83M vs $3M loss.
Full-year 2025 guidance suspended due to leadership change and market headwinds.

item 2.02item 5.02item 5.03item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.